Fig. 1-1.
ASO IgH RT-PCRs were performed on a serial dilution of CD19+/CD20+ and CD19+/CD20− cells (performed by a cell sorter).
The result shown illustrates that therapies using anti-CD20 antibodies only target a subset of the clonotypic B lymphocytes.